These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1626282)
41. Fish oil and rheumatoid arthritis: past, present and future. James M; Proudman S; Cleland L Proc Nutr Soc; 2010 Aug; 69(3):316-23. PubMed ID: 20509981 [TBL] [Abstract][Full Text] [Related]
42. Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Cleland LG; Caughey GE; James MJ; Proudman SM J Rheumatol; 2006 Oct; 33(10):1973-9. PubMed ID: 16881100 [TBL] [Abstract][Full Text] [Related]
43. Diet and fatty acids: can fish substitute for fish oil? Fahrer H; Hoeflin F; Lauterburg BH; Peheim E; Levy A; Vischer TL Clin Exp Rheumatol; 1991; 9(4):403-6. PubMed ID: 1934691 [TBL] [Abstract][Full Text] [Related]
44. Recent advances in rheumatic diseases: the connective tissue diseases other than rheumatoid arthritis--1970 and 1971. Wallace SL; Diamond H; Kaplan D Ann Intern Med; 1972 Sep; 77(3):455-64. PubMed ID: 4403354 [No Abstract] [Full Text] [Related]
47. [Clinical experience with indomethacin]. Feyen H; Hiemeyer V; Pötting H Med Klin; 1968 Oct; 63(40):1593-6. PubMed ID: 5305247 [No Abstract] [Full Text] [Related]
48. [Role of omega-3 polyunsaturated fatty acids in diet of patients with rheumatic diseases]. Sales C; Oliviero F; Spinella P Reumatismo; 2008; 60(2):95-101. PubMed ID: 18651052 [TBL] [Abstract][Full Text] [Related]
49. Effects of fish oil supplementation in rheumatoid arthritis. van der Tempel H; Tulleken JE; Limburg PC; Muskiet FA; van Rijswijk MH Ann Rheum Dis; 1990 Feb; 49(2):76-80. PubMed ID: 2138449 [TBL] [Abstract][Full Text] [Related]
50. [Tumors in rheumatic diseases]. Świerkot J; Lewandowicz-Uszyńska A; Bogunia-Kubik K Postepy Hig Med Dosw (Online); 2013 Dec; 67():1254-60. PubMed ID: 24379265 [TBL] [Abstract][Full Text] [Related]
51. [Azathioprine in rheumatology]. Mathies H Fortschr Med; 1979 Dec; 97(48):2215-7. PubMed ID: 43824 [TBL] [Abstract][Full Text] [Related]
52. Fish oil supplementation in patients with and without systemic lupus erythematosus: targeting pro-inflammatory and pro-resolving lipid mediators. Choi MY; Cook NR; Kotler G; Serhan CN; Tatituri R; Costenbader KH Clin Exp Rheumatol; 2022 Nov; 40(11):2196-2197. PubMed ID: 35894061 [TBL] [Abstract][Full Text] [Related]
53. The role of fish oils in the treatment of rheumatoid arthritis. Cleland LG; James MJ; Proudman SM Drugs; 2003; 63(9):845-53. PubMed ID: 12678571 [TBL] [Abstract][Full Text] [Related]
54. What are the effects of medication adherence interventions in rheumatic diseases: a systematic review. Galo JS; Mehat P; Rai SK; Avina-Zubieta A; De Vera MA Ann Rheum Dis; 2016 Apr; 75(4):667-73. PubMed ID: 25667208 [TBL] [Abstract][Full Text] [Related]
55. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Barbhaiya M; Bermas BL Clin Immunol; 2013 Nov; 149(2):225-35. PubMed ID: 23773975 [TBL] [Abstract][Full Text] [Related]
56. [HEREDITARY FACTORS IN DISSEMINATED LUPUS ERYTHEMATOSUS. CLINICAL AND SEROLOGICAL FAMILIAL INVESTIGATIONS]. THIVOLET J; VERJUS F; KRATCHKO A Ann Dermatol Syphiligr (Paris); 1964; 91():361-78. PubMed ID: 14194827 [No Abstract] [Full Text] [Related]
58. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option. Yoon KH Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225 [TBL] [Abstract][Full Text] [Related]
59. Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases. Filippini P; Del Papa N; Sambataro D; Del Bufalo A; Locatelli F; Rutella S Curr Med Chem; 2012; 19(31):5381-93. PubMed ID: 22963664 [TBL] [Abstract][Full Text] [Related]
60. Vitamin D and rheumatic diseases. Rossini M; Gatti D; Viapiana O; Caimmi C; Idolazzi L; Fracassi E; Adami S Reumatismo; 2014 Jul; 66(2):153-70. PubMed ID: 25069497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]